Torsemide NDC 43353-315

NDC codes

FDA NDC Directory

Product NDC (as listed)43353-315Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43353-0315Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43353-315-16	43353031516	6000 TABLET in 1 BOTTLE, PLASTIC (43353-315-16)Marketed from May 3, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Torsemide
Generic name (nonproprietary): torsemide
Active ingredients: Torsemide — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076943
Marketing start: Mar 3, 2005
Listing expires: Dec 31, 2026
Other FDA classes: Increased Diuresis at Loop of Henle (Physiologic effect)
Identifiers: Product ID 43353-315_cd00a5cc-04b6-49cd-89d0-ae552b415f5dSPL ID cd00a5cc-04b6-49cd-89d0-ae552b415f5dSPL set ID b869bc45-1ebb-42fb-82c5-603f09835790RxCUI 198371UNII W31X2H97FB
Pharmacologic class: Loop Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443353031516 followed by a unit qualifier and the quantity

Package 43353-0315-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 19, 2017.

Indications (excerpt from the label)

Torsemide is a loop diuretic indicated for: • the treatment of edema associated with heart failure, renal disease or hepatic disease. ( 1.1 ) • the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.2 ) 1.1 Edema Torsemide is indicated for the treatment of edema associated with heart failure, renal disease, or hepatic disease. 1.2 Hypertension Torsemide is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. Th…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076943

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076943
Product	Strength	Form · route	Labeler	Product NDC
Torsemide	Torsemide 20 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0077
Torsemide	Torsemide 20 mg/1	TabletOral	REMEDYREPACK INC.	70518-2195
Torsemide	Torsemide 20 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-819
Torsemide	Torsemide 20 mg/1	TabletOral	Golden State Medical Supply, Inc.	51407-362